Canada markets close in 4 hours 22 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1050+0.0050 (+5.00%)
As of 09:30AM EST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,388
1,608
1,342
1,694
Cost of Revenue
1,109
1,039
814.715
1,084
Gross Profit
1,280
568.441
526.859
609.912
Operating Expenses
Research Development
1,402
1,377
1,326
1,541
Selling General and Administrative
3,992
4,075
3,425
2,659
Total Operating Expenses
5,393
5,452
4,751
4,200
Operating Income or Loss
-4,114
-4,884
-4,224
-3,590
Interest Expense
667.558
416.057
121.556
141.675
Total Other Income/Expenses Net
432.184
327.773
461.653
2,771
Income Before Tax
-4,243
-4,850
-3,846
-960.178
Income from Continuing Operations
-4,243
-4,850
-3,846
-960.178
Net Income
-4,289
-4,605
-3,717
-960.178
Net Income available to common shareholders
-4,289
-4,605
-3,717
-960.178
Basic EPS
-
-0.04
-0.03
-0.01
Diluted EPS
-
-0.04
-0.03
-0.01
Basic Average Shares
-
112,600
107,549
101,532
Diluted Average Shares
-
112,600
107,549
101,532
EBITDA
-
-4,246
-3,646
-764.079